Concurrently, TRAIL-loaded LGP nanogels(TRAIL-LGP) activate death receptors DR4/DR5 on HCC cells, amplifyingextrinsic apoptotic signaling. The gene discussed is TNFSF10; the disease is hepatocellular carcinoma.